1-2 of 2
Nuria Martínez-Cibrian
Close
Sort by
Journal Articles

Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplant

Amanda Isabel Pérez-Valencia, Enric Cascos, Sara Carbonell-Ordeig, Paola Charry, Marta Gómez-Hernando, Luis Gerardo Rodríguez-Lobato, María Suárez-Lledó, Nuria Martínez-Cibrian, María Gabriela Antelo, María Teresa Solano, Jordi Arcarons, Meritxell Nomdedeu, Joan Cid, Miquel Lozano, Maribel Díaz-Ricart, Laura Rosiñol, Jordi Esteve, Álvaro Urbano-Ispizua, Enric Carreras, Carmen Martínez, Francesc Fernández-Avilés, Montserrat Rovira, María Queralt Salas
Journal: Blood Advances
Blood Adv (2023) 7 (10): 2018–2031.
https://doi.org/10.1182/bloodadvances.2022008792
Published: 2023
Includes: Supplemental data
Journal Articles

Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma

Gloria Iacoboni, Kai Rejeski, Guillermo Villacampa, Jaap A. van Doesum, Annalisa Chiappella, Francesca Bonifazi, Lucia Lopez-Corral, Michiel van Aalderen, Mi Kwon, Nuria Martínez-Cibrian, Stefania Bramanti, Juan Luis Reguera-Ortega, Lina Camacho-Arteaga, Christian Schmidt, Ana Marín-Niebla, Marie José Kersten, Alejandro Martin Garcia-Sancho, Pier Luigi Zinzani, Paolo Corradini, Tom van Meerten, Marion Subklewe, Pere Barba
Journal: Blood Advances
Blood Adv (2022) 6 (12): 3606–3610.
https://doi.org/10.1182/bloodadvances.2021006922
Published: 2022
Includes: Supplemental data